Shiseido's Strategic Overhaul Yields Profit Growth Amid Sales Decline
Japan's beauty conglomerate Shiseido Group has reported a notable 21.3% rise in core operating profit for the first half of 2025, signaling early success in its transformation strategy despite a 7.6% global sales decline to ¥469 billion (approximately £2.3 billion).
Divergent Regional Performance
The sales downturn was primarily attributed to sluggish consumer spending in China and ongoing challenges in travel retail channels. The Americas market saw a 10.1% year-on-year sales contraction, while EMEA recorded a 5.3% drop, with both regions facing competitive pressure from emerging brands like Drunk Elephant amid subdued cosmetics market growth.
Navigating External Headwinds
Escalating geopolitical tensions, global economic deceleration, and uncertainties surrounding U.S. tariff policies have collectively impacted the multinational's operations. The company noted these factors contributed to underperforming industry growth projections.
Structural Reforms Deliver Results
Under its "SHIFT 2025 and Beyond" midterm strategy, Shiseido achieved 3% global cost efficiencies through organizational restructuring and gross margin optimization. Targeted reforms in its domestic Japanese market proved instrumental in driving profitability.
Two-Year Revival Blueprint
The newly launched "Action Plan 2025-2026" outlines a dual-year roadmap focusing on brand portfolio consolidation, profitable business reconstruction, and enhanced operational governance. This initiative aims to establish a resilient business model capable of sustaining growth in volatile markets, targeting a 7% core operating margin by 2026. The first-phase reforms will prioritize foundational adjustments to secure long-term stability.
2026-07-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Shiseido Americas Plans Major Layoffs amid Sharp Sales Decline
-
Shiseido terminates acquisition of OSEA
-
Shiseido shares fall on China slump
-
Baum to exit China
-
SHISEIDO ACCESSES MAX MARA Fragrance License
-
Shiseido Acquires Dr. Dennis Gross to Strengthen Skin Care Portfolio
-
Shiseido Announces Acquisition of Dr. Dennis Gross
-
Shiseido Develops Tool that Predicts Future Skin Concerns by Analyzing Facial Images
-
Shiseido and Nars Expand Presence in India with Standalone Boutiques
-
Shiseido's classic products usher in an update again
Recommend Reading
-
Procter & Gamble Posts Higher Profits on Strong Personal Care Sales and Recovery in China
-
EPA Reviews Bayer’s New Fungicide Fluoxapiprolin for US Crops Disease Control Expanded Risk Assessed as Low
-
Eli Lilly Strikes $1.3 Billion AI Deal with Superluminal for Next-Gen Obesity Drugs Targets GPCR Breakthrough
-
Eli Lilly to Raise UK Mounjaro Price 170 Percent Monthly Cost Jumps from £122 to £330
-
Mitsubishi Chemical Exits J-Film with 33.6 Billion Yen Sales as Q1 Profit Plunges 50 Percent
-
Global Food Policy Shift 60-Day Rice Import Ban in Philippines EU Issues 5 Recalls on Chinese Exports in One Week
-
FDA Approves Precigen’s Papzimeos Immunotherapy 51 Percent of RRP Patients Avoid Surgery for One Year
-
Premium Global Chemical Sourcing Requests (23-26Apr, 2026)
-
Both Cost and Demand Weaken, PTA Prices Fluctuate and Decline in May
-
Double Negative Impact on Costs and Demand—Polyester Staple Fiber Prices Shift Lower in May